Leiner Sees Gross Margins Improve, Brings Manufacturing In-House
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' gross profit margins continue to improve, with consolidated gross profit margin "returning" to 24.5% for the fourth quarter of fiscal 2006, CEO Robert Kaminski announced during a fourth-quarter and full-year earnings call June 15
You may also be interested in...
Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions
Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call
Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions
Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call
Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions
Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call